ALPHARETTA, Ga., Jan. 6, 2016 /PRNewswire/ -- EndoChoice Holdings, Inc. (NYSE: GI) has been awarded contracts for imaging products, services and infection control products by the group-purchasing unit of Premier Inc. The three-year contract is effective February 1, 2016 through January 31, 2019.
The innovative Fuse Full Spectrum Endoscopy® system will now be available to Premier member facilities. The Fuse system is the only flexible endoscopy system to provide a panoramic 330-degree field of view to physicians and clinical data1 showed a reduction in the number of missed adenomas during colonoscopies. The Fuse gastroscope provides a 245-degree field of view for upper endoscopy procedures. These expanded and wide-angle views are possible because the Fuse colonoscope uses three cameras and two on the gastroscope; previously Premier members only had access to single-imager endoscopes from other companies.
Infection control products by EndoChoice including the patent-protected CinchPad® and EndoKits® are also part of the new contract. Endoscopy procedures involve long, slender cameras that are placed in patients to diagnose and treat a wide range of gastrointestinal conditions and diseases including cancer. Prior to, during and after each procedure, to ensure cross-contamination between patients does not occur healthcare providers must follow important steps and processes. Recently, national headlines have highlighted the importance of adhering to the guidelines from the major medical societies and patients are increasingly concerned about the risk of acquiring an infectious disease from improperly cleaned medical equipment.
EndoChoice's flexible endoscope repair services will be part of the Premier contract as well. Each year there are an estimated 25 million endoscopy procedures performed in the US; the endoscopes used in these procedures require occasional service and repair. Premier members will now be able to have their endoscopes serviced by EndoChoice master technicians.
1 Gralnek et al. Lancet Oncol. 2014: 15: 353-360.
Based near Atlanta, Georgia, EndoChoice (NYSE: GI) is a medtech company focused on the manufacturing and commercialization of platform technologies including endoscopic imaging systems, devices and infection control products and pathology services for specialists treating a wide range of gastrointestinal conditions, including colon cancer. EndoChoice leverages its direct sales organization to serve more than 2,500 customers in the United States and works with distribution partners in 30 countries. The Company was founded in 2008 and has rapidly developed a broad and innovative product portfolio, which includes the Full Spectrum Endoscopy System (Fuse®). EndoChoice, Fuse, and Full Spectrum Endoscopy are registered trademarks of EndoChoice, Inc.
About Premier, Inc.
Premier, Inc. is a leading healthcare improvement company, uniting an alliance of approximately 3,400 U.S. hospitals and 110,000 other providers to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and advisory and other services, Premier enables better care and outcomes at a lower cost. Premier, a Malcolm Baldrige National Quality Award recipient, plays a critical role in the rapidly evolving healthcare industry, collaborating with members to co-develop long-term innovations that reinvent and improve the way care is delivered to patients nationwide. Headquartered in Charlotte, N.C., Premier is passionate about transforming American healthcare. Please visit Premier's news and investor sites on www.premierinc.com; as well as Twitter, Facebook, LinkedIn, YouTube, Instagram, Foursquare and Premier's blog for more information about the company.
David Gill, Chief Financial Officer